Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 💊 [Greenville, South Carolina] Will Hayden Panettiere's death uncover a supplier like Matthew Perry's 'Ketamine Queen'? - latimes.com
- 🌿 [Delaware] Analysis identifies sharply different health risks among medicinal, recreational and dual cannabis users - medicalxpress.com
- 🌿 [WI] Where Tom Tiffany, David Crowley stand on marijuana legalization, hemp - jsonline.com
- 🧠 [International] Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD - drogriporter.hu
- 🗳️ [New York] New York’s nicotine pouch tax gets the math — and the policy — wrong - nydailynews.com
🗣️ Social Pulse
Lived/Living Experience
Innovation
- 🧮 Run a simulation through all this data through every town, not every town but every major city that would’ve been affected by any of these industries closing and leaving, and then run a simultaneous simulation for... - @KsiZegulite on X
- 🗣️ “Building an Overdose Spike Response Plan” helps teams use ODMAP and communication strategies to strengthen partnerships with public health and safety agencies. Explore the free webinar here: - @SIM_MONTANA on X
Opposition Views
📚 Academic Research
- 💉 From custody to abandonment: Conceptualising Aboriginal people's drug treatment discontinuation after release - International Journal of Drug Policy - 2026-09-10 - doi.org
- 💊 Assessment of methadone maintenance therapy implementation and perceived barriers to treatment participation - Medicine - 2026-09-11 - doi.org
- 💊 Timing of Initiation of Methadone Take-Home Dosing - JAMA Internal Medicine - 2026-09-08 - doi.org
⚖️ Law & Policy
- No hits in Law and Policy today.
💸 Funding
Current
- Deadline Approaching💊 Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- Deadline Approaching🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- 🔬 National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🏥 Hearst Foundations - Health - Hearst Foundations Health funding (rolling application; no deadlines) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 💡 Smart Family Fund - First time grants range from $25,000 to $100,000. - Deadline: Open pitch